Loading...
We would love for you to become a part of our community. Join our Discord to connect with us and other members!
- Ticker
- ALIF-B.ST
- Price
- 137.30
- Stock movement down
- -2.90 (-2.07%)
- Company name
- AddLife AB (publ)
- Exchange
- (ST ,
- Currency
- SEK )
- Sector
- Healthcare >Medical Instruments & Supplies
- Markedsværdi
- 16.10B
- Ent værdi
- 23.65B
- Pris/omsætning
- 1.61
- Pris/bog
- 3.14
- Udbytte afkast
- -
- Udbyttevækst
- -
- Vekst år
- -
- FCF-udbetaling
- 9.12%
- Efterfølgende P/E
- 137.64
- Fremtidig P/E
- 25.29
- PEG
- -
- EPS-vekst
- 4.10%
- 1 års afkast
- 25.85%
- 3 års afkast
- -28.96%
- 5 års afkast
- 50.03%
- 10 års afkast
- -
Senest opdateret: 2025-01-02
UDBYTTE
ALIF-B.ST betaler ikke udbytte
VÆRDIANSÆTTELSE
Værdiansættelsesforhold
Loading...
Værdiansættelsesforhold-data
| Efterfølgende P/E | 137.64 |
| Pris til OCF | 18.36 |
| Pris til FCF | 24.07 |
| Pris til EBITDA | 12.03 |
| EV i forhold til EBITDA | 17.67 |
Værdiansættelse (salg/bogført værdi)
Loading...
Værdiansættelse (salg/bogført værdi)-data
| Pris til omsætning | 1.61 |
| Pris til egenkapital | 3.14 |
| EV i forhold til salg | 2.36 |
ØKONOMI
Pr. aktie
Loading...
Data pr. aktie
| Aktuelt antal aktier | 117.29M |
| EPS (TTM) | 0.96 |
| FCF pr. aktie (TTM) | 5.49 |
Resultatopgørelse
Loading...
Resultatopgørelse-data
| Omsætning (TTM) | 10.01B |
| Bruttofortjeneste (TTM) | 3.73B |
| Driftsindkomst (TTM) | 610.00M |
| Nettoindkomst (TTM) | 117.00M |
| EPS (TTM) | 0.96 |
| EPS (1 år frem) | 5.43 |
Marginer
Loading...
Marginer-data
| Bruttomargin (TTM) | 37.31% |
| Driftsmargin (TTM) | 6.09% |
| Fortjenstmargin (TTM) | 1.17% |
Balance
Loading...
Opret en gratis konto eller log ind for at få adgang til dette diagram
Balancedata
| Kontanter | 264.00M |
| Nettotilgodehavender | 1.79B |
| Omsætningsaktiver i alt | 3.81B |
| Goodwill | 5.45B |
| Immaterielle aktiver | 2.48B |
| Ejendomme, anlæg og udstyr | 0.00 |
| Sum aktiver | 12.94B |
| Kreditor | 1.78B |
| Kortfristet/nuværende langsigtet gæld | 5.44B |
| Summen af kortfristede forpligtelser | 3.22B |
| Sum gæld | 7.81B |
| Aktionærernes egenkapital | 5.13B |
| Materielle nettoaktiver | 0.00 |
Likviditet
Loading...
Opret en gratis konto eller log ind for at få adgang til dette diagram
Kontantstrøm-data
| Likviditet fra driften (TTM) | 877.00M |
| Investeringsudgifter (TTM) | 208.00M |
| Fri pengestrøm (TTM) | 669.00M |
| Udbetalt udbytte (TTM) | 61.00M |
Finansiel indkomst
Loading...
Opret en gratis konto eller log ind for at få adgang til dette diagram
Data om finansiel indkomst
| Egenkapitalafkast | 2.28% |
| Afkast af aktiver | 0.90% |
| Afkast af investeret kapital | 1.79% |
| Kontant afkast af investeret kapital | 10.24% |
INFORMATION OM AKTIER
Aktiediagram
Loading...
Aktiekurs-data
| Åbning | 140.00 |
| Daglig høj | 141.00 |
| Daglig lav | 135.40 |
| Daglig volumen | 115K |
| Højeste gennem alle tider | 390.00 |
| 1 års analytiker estimat | 165.50 |
| Beta | 1.35 |
| EPS (TTM) | 0.96 |
| Udbytte pr. aktie | - |
| Ex-div dato | 10 May 2024 |
| Næste dato for resultatpræsentation | 5 Feb 2025 |
Nedsidepotensial
Loading...
Nedsidepotensial-data
| ALIF-B.ST | S&P500 | |
| Nuværende prisfald fra top notering | -64.79% | -3.22% |
| Højeste prisfald | -85.64% | -56.47% |
| Højeste efterår dato | 25 Oct 2023 | 9 Mar 2009 |
| Gennemsnitlig fald fra toppen | -34.28% | -11.12% |
| Gennemsnitlig tid til nyt højdepunkt | 17 days | 12 days |
| Maks. tid til nyt højdepunkt | 829 days | 1805 days |
OPLYSNINGER OM VIRKSOMHEDEN
Markedsværdi
16.10B
Markedsværdi kategori
Large-cap
Beskrivelse
AddLife AB (publ), together with its subsidiaries, provides equipment, consumables, and reagents primarily to healthcare sector, research, colleges, and universities, as well as the food and pharmaceutical industries. The company operates through Labtech and Medtech segments. The Labtech segment offers products, solutions, and services in the areas of diagnostics, and biomedical research and laboratory equipment for plastic consumables, cell biology, reagents, lab, and other instruments. The Medtech segment provides medical device products for surgery, thoracic medicine, neurology, wound care, anaesthesia, intensive care, ear, nose and throat, ostomies, and home healthcare, as well as assistive technology for senior citizens and disabled children. It operates in Sweden, the United Kingdom, Ireland, Spain, Denmark, Norway, Italy, Finland, Switzerland, Germany, rest of Europe, and internationally. AddLife AB (publ) was founded in 1906 and is based in Stockholm, Sweden.
Personale
2356
Hjemmeside
Investor relationer
-
SEC-indsendelser
Adm. direktør
Land
Sweden
By
Aktietype
-
CCC-status
-
Utbyttefrekvens
-
ARRANGEMENTER OG PRÆSENTATIONER
ArrangementerPræsentationer
Loading...
FORSTÅ FORRETNINGEN
Loading...
NYHEDER OM VIRKSOMHEDEN
Alle nyhederPressemeddelelser
Despite stable organic growth and strategic acquisitions, AddLife AB faces market hesitancies and regional disruptions impacting performance.
24. oktober 2024
AddLife AB (FRA:1AD1) reports robust revenue and EBITDA growth, with strategic acquisitions enhancing its market position despite ongoing challenges.
9. oktober 2024
As global markets show signs of recovery, with small-cap stocks like the Russell 2000 Index recently outperforming their larger counterparts, investors may find potential opportunities in undervalued ...
19. juli 2024
Amid a notably broad advance in global markets, the Russell 2000 Index recently showcased a significant upswing, outperforming major indices with a 6.00% gain—the best since early November. This posit...
18. juli 2024
As global markets exhibit a notably broad advance, with small-cap stocks like those in the Russell 2000 Index showing significant gains, investors are keenly observing shifts in economic indicators an...
16. juli 2024
As global markets exhibit mixed signals with the S&P 500 reaching new heights amidst a cooling labor market and falling interest rates, investors are keenly observing shifts in economic indicators tha...
12. juli 2024
As global markets exhibit mixed signals with the S&P 500 reaching new heights while small-cap indices like the Russell 2000 show marginal declines, investors are navigating a complex landscape. Econom...
8. juli 2024